PainReform Ltd.

NASDAQ (USD): PainReform Ltd. (PRFX)

Last Price

11.25

Today's Change

+9.06 (413.69%)

Day's Change

4.56 - 16.63

Trading Volume

76,689,898

Overview

Market Cap

6 Million

Shares Outstanding

590,616

Avg Volume

4,101,523

Avg Price (50 Days)

1.53

Avg Price (200 Days)

3.61

PE Ratio

-0.08

EPS

-147.36

Earnings Announcement

27-Feb-2025

Previous Close

2.19

Open

5.36

Day's Range

4.56 - 16.63

Year Range

0.432 - 20.16

Trading Volume

76,695,578

Price Change Highlight

1 Day Change

401.80%

5 Day Change

295.37%

1 Month Change

98.39%

3 Month Change

269.10%

6 Month Change

-1.59%

Ytd Change

-82.06%

1 Year Change

-82.20%

3 Year Change

-96.68%

5 Year Change

-99.31%

10 Year Change

-99.31%

Max Change

-99.31%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Drug Manufacturers—Specialty & Generic

Description:

PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company is currently conducting two Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. PainReform Ltd. was incorporated in 2007 and is based in Tel Aviv, Israel.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment